UniProt ID | PDIP3_HUMAN | |
---|---|---|
UniProt AC | Q9BY77 | |
Protein Name | Polymerase delta-interacting protein 3 | |
Gene Name | POLDIP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 421 | |
Subcellular Localization | Nucleus. Nucleus speckle. Cytoplasm. Nucleocytoplasmic shuttling protein. | |
Protein Description | Is involved in regulation of translation. Is preferentially associated with CBC-bound spliced mRNA-protein complexes during the pioneer round of mRNA translation. Contributes to enhanced translational efficiency of spliced over nonspliced mRNAs. Recruits activated ribosomal protein S6 kinase beta-1 I/RPS6KB1 to newly synthesized mRNA. Involved in nuclear mRNA export; probably mediated by assoociation with the TREX complex.. | |
Protein Sequence | MADISLDELIRKRGAAAKGRLNARPGVGGVRSRVGIQQGLLSQSTRTATFQQRFDARQKIGLSDARLKLGVKDAREKLLQKDARFRIKGKVQDAREMLNSRKQQTTVPQKPRQVADAREKISLKRSSPAAFINPPIGTVTPALKLTKTIQVPQQKAMAPLHPHPAGMRINVVNNHQAKQNLYDLDEDDDGIASVPTKQMKFAASGGFLHHMAGLSSSKLSMSKALPLTKVVQNDAYTAPALPSSIRTKALTNMSRTLVNKEEPPKELPAAEPVLSPLEGTKMTVNNLHPRVTEEDIVELFCVCGALKRARLVHPGVAEVVFVKKDDAITAYKKYNNRCLDGQPMKCNLHMNGNVITSDQPILLRLSDSPSMKKESELPRRVNSASSSNPPAEVDPDTILKALFKSSGASVTTQPTEFKIKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADISLDEL ------CCCCCHHHH | 23.89 | 22223895 | |
5 | Phosphorylation | ---MADISLDELIRK ---CCCCCHHHHHHH | 30.25 | 25159151 | |
11 | Methylation | ISLDELIRKRGAAAK CCHHHHHHHHCHHHH | 34.93 | 115917017 | |
33 | Methylation | GVGGVRSRVGIQQGL CCCCHHHHHHHCCCC | 21.81 | 24129315 | |
42 | Phosphorylation | GIQQGLLSQSTRTAT HHCCCCCCCCCCCCH | 27.42 | 17525332 | |
44 | Phosphorylation | QQGLLSQSTRTATFQ CCCCCCCCCCCCHHH | 19.24 | 23911959 | |
45 | Phosphorylation | QGLLSQSTRTATFQQ CCCCCCCCCCCHHHH | 25.13 | 26074081 | |
63 | Phosphorylation | ARQKIGLSDARLKLG HHHHHCCCHHHHHHC | 24.82 | 20068231 | |
66 | Methylation | KIGLSDARLKLGVKD HHCCCHHHHHHCCHH | 37.03 | 115917021 | |
72 | Acetylation | ARLKLGVKDAREKLL HHHHHCCHHHHHHHH | 43.82 | 25953088 | |
88 | Methylation | KDARFRIKGKVQDAR CCCHHHHCCHHHHHH | 48.71 | 116253695 | |
102 | Ubiquitination | REMLNSRKQQTTVPQ HHHHHCCCCCCCCCC | 46.72 | - | |
102 | Methylation | REMLNSRKQQTTVPQ HHHHHCCCCCCCCCC | 46.72 | 116253689 | |
105 | Phosphorylation | LNSRKQQTTVPQKPR HHCCCCCCCCCCCHH | 27.54 | 20363803 | |
106 | Phosphorylation | NSRKQQTTVPQKPRQ HCCCCCCCCCCCHHH | 26.33 | 20363803 | |
110 | Ubiquitination | QQTTVPQKPRQVADA CCCCCCCCHHHHHHH | 35.78 | - | |
122 | Phosphorylation | ADAREKISLKRSSPA HHHHHHHCCCCCCCC | 38.62 | 29449344 | |
126 | Phosphorylation | EKISLKRSSPAAFIN HHHCCCCCCCCCCCC | 38.80 | 29255136 | |
127 | Phosphorylation | KISLKRSSPAAFINP HHCCCCCCCCCCCCC | 23.69 | 29255136 | |
138 (in isoform 2) | Phosphorylation | - | 23.17 | 25159151 | |
138 | Phosphorylation | FINPPIGTVTPALKL CCCCCCCCCCHHHHC | 23.17 | 25159151 | |
140 (in isoform 2) | Phosphorylation | - | 11.59 | 25159151 | |
140 | Phosphorylation | NPPIGTVTPALKLTK CCCCCCCCHHHHCCC | 11.59 | 23927012 | |
144 | Acetylation | GTVTPALKLTKTIQV CCCCHHHHCCCEECC | 57.10 | 25953088 | |
144 | Ubiquitination | GTVTPALKLTKTIQV CCCCHHHHCCCEECC | 57.10 | - | |
146 | Phosphorylation | VTPALKLTKTIQVPQ CCHHHHCCCEECCCC | 25.26 | 23312004 | |
147 (in isoform 2) | Ubiquitination | - | 54.81 | - | |
147 | Ubiquitination | TPALKLTKTIQVPQQ CHHHHCCCEECCCCC | 54.81 | - | |
148 (in isoform 2) | Phosphorylation | - | 16.06 | 28796482 | |
153 (in isoform 2) | Phosphorylation | - | 59.56 | 28796482 | |
155 | Ubiquitination | TIQVPQQKAMAPLHP EECCCCCCCCCCCCC | 34.58 | - | |
168 (in isoform 2) | Ubiquitination | - | 19.19 | 21890473 | |
171 (in isoform 2) | Ubiquitination | - | 4.54 | - | |
178 | Ubiquitination | VVNNHQAKQNLYDLD EECCCHHHHCCCCCC | 32.90 | - | |
182 | Phosphorylation | HQAKQNLYDLDEDDD CHHHHCCCCCCCCCC | 23.24 | 28796482 | |
193 | Phosphorylation | EDDDGIASVPTKQMK CCCCCCCCCCHHHEE | 27.06 | 24532841 | |
197 | Ubiquitination | GIASVPTKQMKFAAS CCCCCCHHHEEEHHC | 42.18 | 21906983 | |
200 (in isoform 2) | Ubiquitination | - | 29.38 | 21890473 | |
200 | Ubiquitination | SVPTKQMKFAASGGF CCCHHHEEEHHCCCH | 29.38 | 21890473 | |
200 | Sumoylation | SVPTKQMKFAASGGF CCCHHHEEEHHCCCH | 29.38 | 28112733 | |
204 | Phosphorylation | KQMKFAASGGFLHHM HHEEEHHCCCHHHHH | 35.70 | 28450419 | |
214 (in isoform 1) | Ubiquitination | - | 3.05 | 21890473 | |
215 | Phosphorylation | LHHMAGLSSSKLSMS HHHHCCCCCCCCCHH | 31.48 | 25159151 | |
216 | Phosphorylation | HHMAGLSSSKLSMSK HHHCCCCCCCCCHHH | 36.21 | 29396449 | |
217 | Phosphorylation | HMAGLSSSKLSMSKA HHCCCCCCCCCHHHH | 33.95 | 29396449 | |
218 | Acetylation | MAGLSSSKLSMSKAL HCCCCCCCCCHHHHC | 46.67 | 25953088 | |
223 | Sumoylation | SSKLSMSKALPLTKV CCCCCHHHHCCCCEE | 45.35 | 28112733 | |
223 | Ubiquitination | SSKLSMSKALPLTKV CCCCCHHHHCCCCEE | 45.35 | - | |
229 | Ubiquitination | SKALPLTKVVQNDAY HHHCCCCEEECCCCC | 48.36 | 21890473 | |
236 | Phosphorylation | KVVQNDAYTAPALPS EEECCCCCCCCCCCH | 13.29 | 21945579 | |
237 | Phosphorylation | VVQNDAYTAPALPSS EECCCCCCCCCCCHH | 28.08 | 21945579 | |
243 | Phosphorylation | YTAPALPSSIRTKAL CCCCCCCHHHHHHHH | 38.97 | 21945579 | |
244 | Phosphorylation | TAPALPSSIRTKALT CCCCCCHHHHHHHHH | 17.72 | 21945579 | |
247 | Phosphorylation | ALPSSIRTKALTNMS CCCHHHHHHHHHHHC | 20.99 | 26074081 | |
248 | Ubiquitination | LPSSIRTKALTNMSR CCHHHHHHHHHHHCC | 31.39 | - | |
248 | Sumoylation | LPSSIRTKALTNMSR CCHHHHHHHHHHHCC | 31.39 | 28112733 | |
251 | Phosphorylation | SIRTKALTNMSRTLV HHHHHHHHHHCCCCC | 33.46 | 29978859 | |
254 | Phosphorylation | TKALTNMSRTLVNKE HHHHHHHCCCCCCCC | 24.96 | 28985074 | |
256 | Phosphorylation | ALTNMSRTLVNKEEP HHHHHCCCCCCCCCC | 27.96 | 28387310 | |
260 | Acetylation | MSRTLVNKEEPPKEL HCCCCCCCCCCCCCC | 56.85 | 26051181 | |
260 | Ubiquitination | MSRTLVNKEEPPKEL HCCCCCCCCCCCCCC | 56.85 | - | |
265 | Ubiquitination | VNKEEPPKELPAAEP CCCCCCCCCCCCCCC | 80.66 | - | |
265 | Acetylation | VNKEEPPKELPAAEP CCCCCCCCCCCCCCC | 80.66 | 26051181 | |
275 | Phosphorylation | PAAEPVLSPLEGTKM CCCCCCCCCCCCCCC | 27.89 | 29255136 | |
280 | Phosphorylation | VLSPLEGTKMTVNNL CCCCCCCCCCCCCCC | 14.31 | 29255136 | |
303 (in isoform 2) | Ubiquitination | - | 2.51 | 21890473 | |
307 | Acetylation | FCVCGALKRARLVHP HHHHHHHHHHCCCCC | 43.40 | 20167786 | |
323 | Acetylation | VAEVVFVKKDDAITA EEEEEEEECCCHHHH | 38.73 | 26051181 | |
329 | Phosphorylation | VKKDDAITAYKKYNN EECCCHHHHHHHHCC | 26.17 | - | |
332 | Ubiquitination | DDAITAYKKYNNRCL CCHHHHHHHHCCEEC | 46.44 | 2190698 | |
349 (in isoform 1) | Ubiquitination | - | 8.15 | 21890473 | |
366 | Phosphorylation | QPILLRLSDSPSMKK CCEEEEECCCCCCCC | 29.61 | 24732914 | |
368 | Phosphorylation | ILLRLSDSPSMKKES EEEEECCCCCCCCHH | 18.59 | 23401153 | |
370 | Phosphorylation | LRLSDSPSMKKESEL EEECCCCCCCCHHHC | 47.38 | 25159151 | |
372 | Ubiquitination | LSDSPSMKKESELPR ECCCCCCCCHHHCCC | 58.70 | - | |
372 | Sumoylation | LSDSPSMKKESELPR ECCCCCCCCHHHCCC | 58.70 | 28112733 | |
373 | Ubiquitination | SDSPSMKKESELPRR CCCCCCCCHHHCCCC | 58.81 | - | |
375 | Phosphorylation | SPSMKKESELPRRVN CCCCCCHHHCCCCCC | 54.00 | 24732914 | |
383 | Phosphorylation | ELPRRVNSASSSNPP HCCCCCCCCCCCCCC | 27.03 | 29255136 | |
385 | Phosphorylation | PRRVNSASSSNPPAE CCCCCCCCCCCCCCC | 33.83 | 29255136 | |
386 | Phosphorylation | RRVNSASSSNPPAEV CCCCCCCCCCCCCCC | 33.57 | 29255136 | |
387 | Phosphorylation | RVNSASSSNPPAEVD CCCCCCCCCCCCCCC | 51.35 | 29255136 | |
400 | Ubiquitination | VDPDTILKALFKSSG CCHHHHHHHHHHCCC | 38.91 | - | |
404 | Ubiquitination | TILKALFKSSGASVT HHHHHHHHCCCCCCC | 44.56 | - | |
404 | Methylation | TILKALFKSSGASVT HHHHHHHHCCCCCCC | 44.56 | 115981161 | |
405 | Phosphorylation | ILKALFKSSGASVTT HHHHHHHCCCCCCCC | 27.03 | 22817900 | |
406 | Phosphorylation | LKALFKSSGASVTTQ HHHHHHCCCCCCCCC | 38.68 | 22817900 | |
409 | Phosphorylation | LFKSSGASVTTQPTE HHHCCCCCCCCCCCE | 24.42 | 23312004 | |
411 | Phosphorylation | KSSGASVTTQPTEFK HCCCCCCCCCCCEEE | 19.74 | 23312004 | |
412 | Phosphorylation | SSGASVTTQPTEFKI CCCCCCCCCCCEEEE | 30.32 | 23312004 | |
418 | Methylation | TTQPTEFKIKL---- CCCCCEEEECC---- | 32.47 | 30795303 | |
418 | Ubiquitination | TTQPTEFKIKL---- CCCCCEEEECC---- | 32.47 | - | |
418 | Sumoylation | TTQPTEFKIKL---- CCCCCEEEECC---- | 32.47 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
63 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
383 | S | Phosphorylation | Kinase | KS6B1 | P23443 | PhosphoELM |
383 | S | Phosphorylation | Kinase | P70-SUBFAMILY | - | GPS |
385 | S | Phosphorylation | Kinase | P70S6K | P23443 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDIP3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KS6B1_HUMAN | RPS6KB1 | physical | 15341740 | |
NCBP1_HUMAN | NCBP1 | physical | 18423201 | |
IF4A3_HUMAN | EIF4A3 | physical | 18423201 | |
IF4G1_HUMAN | EIF4G1 | physical | 25049393 | |
LZTS2_HUMAN | LZTS2 | physical | 25416956 | |
K1C40_HUMAN | KRT40 | physical | 25416956 | |
IMA4_HUMAN | KPNA3 | physical | 26186194 | |
UBR1_HUMAN | UBR1 | physical | 28514442 | |
KLH22_HUMAN | KLHL22 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127, AND MASSSPECTROMETRY. | |
"SKAR is a specific target of S6 kinase 1 in cell growth control."; Richardson C.J., Broenstrup M., Fingar D.C., Julich K., Ballif B.A.,Gygi S., Blenis J.; Curr. Biol. 14:1540-1549(2004). Cited for: INTERACTION WITH RPS6KB1, SUBCELLULAR LOCATION, PHOSPHORYLATION ATSER-127; SER-275; SER-383 AND SER-385, MUTAGENESIS OF SER-383 ANDSER-385, AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-140, AND MASSSPECTROMETRY. |